Elanco Animal Health’s methane reducing product for cattle could provide “blockbuster revenue potential” in excess of $200 million, according to Elanco CEO and President Jeff Simmons.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
